Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - EQ 10MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20551
DOSAGE - INJECTABLE;INJECTION - EQ 2MG BASE/M...DOSAGE - INJECTABLE;INJECTION - EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20551
Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Topical
Solubilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
65
PharmaCompass offers a list of Cisatracurium Besylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cisatracurium Besylate manufacturer or Cisatracurium Besylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cisatracurium Besylate manufacturer or Cisatracurium Besylate supplier.
PharmaCompass also assists you with knowing the Cisatracurium Besylate API Price utilized in the formulation of products. Cisatracurium Besylate API Price is not always fixed or binding as the Cisatracurium Besylate Price is obtained through a variety of data sources. The Cisatracurium Besylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cis Atracurium Besylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cis Atracurium Besylate, including repackagers and relabelers. The FDA regulates Cis Atracurium Besylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cis Atracurium Besylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cis Atracurium Besylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cis Atracurium Besylate supplier is an individual or a company that provides Cis Atracurium Besylate active pharmaceutical ingredient (API) or Cis Atracurium Besylate finished formulations upon request. The Cis Atracurium Besylate suppliers may include Cis Atracurium Besylate API manufacturers, exporters, distributors and traders.
click here to find a list of Cis Atracurium Besylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cis Atracurium Besylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Cis Atracurium Besylate active pharmaceutical ingredient (API) in detail. Different forms of Cis Atracurium Besylate DMFs exist exist since differing nations have different regulations, such as Cis Atracurium Besylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cis Atracurium Besylate DMF submitted to regulatory agencies in the US is known as a USDMF. Cis Atracurium Besylate USDMF includes data on Cis Atracurium Besylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cis Atracurium Besylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cis Atracurium Besylate suppliers with USDMF on PharmaCompass.
A Cis Atracurium Besylate CEP of the European Pharmacopoeia monograph is often referred to as a Cis Atracurium Besylate Certificate of Suitability (COS). The purpose of a Cis Atracurium Besylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cis Atracurium Besylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cis Atracurium Besylate to their clients by showing that a Cis Atracurium Besylate CEP has been issued for it. The manufacturer submits a Cis Atracurium Besylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cis Atracurium Besylate CEP holder for the record. Additionally, the data presented in the Cis Atracurium Besylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cis Atracurium Besylate DMF.
A Cis Atracurium Besylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cis Atracurium Besylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cis Atracurium Besylate suppliers with CEP (COS) on PharmaCompass.
A Cis Atracurium Besylate written confirmation (Cis Atracurium Besylate WC) is an official document issued by a regulatory agency to a Cis Atracurium Besylate manufacturer, verifying that the manufacturing facility of a Cis Atracurium Besylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cis Atracurium Besylate APIs or Cis Atracurium Besylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Cis Atracurium Besylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Cis Atracurium Besylate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cis Atracurium Besylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cis Atracurium Besylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cis Atracurium Besylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cis Atracurium Besylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cis Atracurium Besylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cis Atracurium Besylate suppliers with NDC on PharmaCompass.
Cis Atracurium Besylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cis Atracurium Besylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cis Atracurium Besylate GMP manufacturer or Cis Atracurium Besylate GMP API supplier for your needs.
A Cis Atracurium Besylate CoA (Certificate of Analysis) is a formal document that attests to Cis Atracurium Besylate's compliance with Cis Atracurium Besylate specifications and serves as a tool for batch-level quality control.
Cis Atracurium Besylate CoA mostly includes findings from lab analyses of a specific batch. For each Cis Atracurium Besylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cis Atracurium Besylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cis Atracurium Besylate EP), Cis Atracurium Besylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cis Atracurium Besylate USP).
